Capricor Therapeutics (NASDAQ:CAPR) shareholder returns have been enviable, earning 685% in 5 years – Simply Wall St

Capricor Therapeutics (NASDAQ:CAPR) shareholders have enjoyed impressive returns, with a 685% increase over the past 5 years according to Simply Wall St.